Last update:

Clinical pharmacology news

Natural compounds against sarcoma: Which one shows the greatest potential?

Curcumin, berberine and other plant-derived compounds have long attracted scientific interest because of their anti-inflammatory and anticancer properties. A new study by researchers from Wroclaw Medical University and the ...

Newly identified molecule could help regulate sleep

Sleep is known to be essential for survival, as it allows both humans and other animals to rest, while the brain consolidates memories and clears out metabolic waste products. For many people worldwide, however, falling asleep ...

Viagra may reduce cancer metastasis, study shows

Viagra was originally developed to treat high blood pressure and chest pain caused by reduced blood flow to the heart, but over the past three decades it has become the world's best-known therapy for erectile dysfunction. ...

One of the oldest psychedelics meets modern brain imaging

For millennia, people have used the psychedelic mescaline as a spiritual and religious tool. Mescaline is a naturally occurring chemical found in cacti, mainly peyote cacti, that are located in the Southwest United States ...

Researchers study barriers to GLP-1 insurance coverage

Despite growing evidence that GLP-1 medications improve health and are worth their cost, many insurance plans still limit coverage. University of Mississippi researchers are examining why and where that leaves patients.

Q&A: Psychedelics, cannabis, GLP-1s and drug policy changes

From headlines and social media, psychedelic therapies, cannabis use and GLP-1 medications have seemingly become commonplace overnight, but the science underlying these treatments and the pathway to drug approval are often ...

Rise of GLP-1s raises long-term affordability questions

As use of GLP-1s surged across the U.S., average total payments per user also climbed sharply, according to a new Northwestern University study that analyzed national trends in GLP-1 use and spending between 2017 and 2022. ...

Drug hope for people with common heart thickening disease

A new drug offers hope for people with hypertrophic cardiomyopathy, the world's most common inherited heart disease. The TEMPEST trial, led by University of Manchester researchers, tested the drug—called trientine—in 154 ...

New malaria drug candidate shows promise in Phase I trial

The early-stage trial of a potential novel nonartemisinin malaria drug found it rapidly killed malaria parasites and was generally well tolerated in infected volunteers, showing it is a promising candidate for uncomplicated ...

Weight loss drugs could help with binge eating disorder

Drugs commonly used for weight loss, known as GLP-1 receptor agonists, have been found to reduce the key symptoms of binge eating disorder in a new review of evidence led by University College London (UCL) researchers.